Reaction

Neuropathic Muscular Atrophy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 97 reports · 2 co-occurring drugs

As of the last recalculation, Neuropathic Muscular Atrophy appears in 97 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is OFATUMUMAB (PRR 88.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ofatumumab1288.388.3
Botulinum Toxin Type A472.172.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.